RGS8: A Potential Drug Target for Various Diseases (G85397)

Target Name: RGS8

NCBI ID: G85397

RGS8

RGS8: A Potential Drug Target for Various Diseases

RGS8 (OTTHUMP00000033156) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of cell growth, differentiation, and survival. In recent years, researchers have conducted in-depth studies of this protein and discovered its important role in a variety of diseases. This article will review the biological functions, action targets and drug targets of RGS8.

biological functions

RGS8 is a non-coding RNA that plays an important role in a variety of biological processes. It plays a key role in cell proliferation, differentiation and apoptosis. RGS8 can bind to DNA and control the cell cycle by regulating gene expression. It also plays an important role in apoptosis and can regulate the timing and manner of apoptosis. In addition, RGS8 is also involved in cell migration and extracellular matrix formation.

target

The targets of RGS8 include a variety of proteins, such as PDGF, TGF-β, FGF, Notch and Hedgehog. These proteins are closely related to cell proliferation, differentiation and apoptosis. RGS8 regulates the biological activity of these proteins by binding to them. For example, RGS8 can bind to PDGF to inhibit cell proliferation and differentiation, thereby inhibiting tumor growth.

drug target

RGS8 is a potential drug target because it is closely related to various diseases. Currently, a variety of drugs that inhibit RGS8 have entered clinical trials. For example, repaglinide is a drug that inhibits RGS8 and is used to treat diabetes. In addition, RGS8 has also been used as a potential drug target to treat other diseases, such as lung cancer, liver cancer, and breast cancer.

in conclusion

RGS8 is an important protein that plays an important role in cell proliferation, differentiation and apoptosis. It regulates cell biological activity by binding to a variety of proteins. Currently, RGS8 is a potential drug target, and a variety of drugs that inhibit RGS8 have entered clinical trials. Future research will further investigate the biological functions, action targets and drug targets of RGS8 to better understand its application value in medicine.

Protein Name: Regulator Of G Protein Signaling 8

Functions: Regulates G protein-coupled receptor signaling cascades, including signaling via muscarinic acetylcholine receptor CHRM2 and dopamine receptor DRD2 (By similarity). Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:18434541). Modulates the activity of potassium channels that are activated in response to DRD2 and CHRM2 signaling (By similarity)

The "RGS8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RGS8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets